clinical trial · NCT06312189
Long-term Study to Evaluate Safety and Tolerability of Valbenazine in Participants With Chorea Associated With Huntington Disease in Canada
Chorea, HuntingtonValbenazine
brief summary
This study will evaluate long-term safety and tolerability of valbenazine in participants with chorea associated with Huntington Disease (HD) who participated in Study NBI-98854-HD3006 (NCT04400331) in Canada.
started
Apr 24, 2024
primary completion
Apr 1, 2026
completion
Apr 1, 2026
last updated
Apr 9, 2026
official title
Open-Label Study of Valbenazine for the Treatment of Chorea Associated With Huntington Disease in Canada
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol